Gossypol, a phytochemical with BH3-mimetic property, sensitizes cultured thoracic cancer cells to Apo2 ligand/tumor necrosis factor–related apoptosis-inducing ligand
- 1 December 2006
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 132 (6) , 1356-1362.e2
- https://doi.org/10.1016/j.jtcvs.2006.07.025
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The Essential Role of the Mitochondria-Dependent Death-Signaling Cascade in Chemotherapy-Induced Potentiation of Apo2L/TRAIL Cytotoxicity in Cultured Thoracic Cancer CellsThe Cancer Journal, 2006
- Valproic Acid, an Antiepileptic Drug with Histone Deacetylase Inhibitory Activity, Potentiates the Cytotoxic Effect of Apo2L/TRAIL on Cultured Thoracic Cancer Cells through Mitochondria-Dependent Caspase ActivationNeoplasia, 2006
- HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivoBritish Journal of Cancer, 2005
- Histone deacetylase inhibitors potentiate TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in lymphoid malignanciesCell Death & Differentiation, 2004
- Mechanisms of resistance to TRAIL-induced apoptosis in cancerCancer Gene Therapy, 2004
- Drug-mediated sensitization to TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma cells proceeds via activation of intrinsic and extrinsic pathways and caspase-dependent cleavage of XIAP, Bcl-xL and RIPOncogene, 2004
- Apo2L/TRAIL and its death and decoy receptorsCell Death & Differentiation, 2003
- Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versionsNature Medicine, 2001
- Safety and antitumor activity of recombinant soluble Apo2 ligandJournal of Clinical Investigation, 1999
- THE MITOCHONDRIAL DEATH/LIFE REGULATOR IN APOPTOSIS AND NECROSISAnnual Review of Physiology, 1998